Healthcare M&A Report Q4 2017

Size: px

Start display at page:

Download "Healthcare M&A Report Q4 2017"

Ami McCormick
5 years ago
Views:

John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.

1 John Hill Senior Managing Director (813) John McDonald Senior Managing Director (813) Keith Hodgdon Managing Director (813) Healthcare M&A Report Q Charlie Hendrick Vice President (813) Jeffrey Hendricks Vice President (678) Tim Knerr Vice President (813) Hyde Park Capital Advisors, LLC 701 N. Franklin Street Tampa, FL Tel: Member FINRA/SIPC

2 Capital Markets Overview Healthcare Commentary Select Public Offerings Healthcare (Q4 2017) Major market indices including the Nasdaq, S&P 500 and S&P Global Healthcare Index posted positive results over the 12-month period ended December 31, 2017, increasing 27.2%, 18.4%, and 17.5%, respectively. The table to the right highlights select public offerings completed in the Healthcare industry during Q Denali Therapeutics, Inc. (NASDAQ:DNLI), a biopharmaceutical company, completed the largest IPO during the quarter, raising $250 million from investors. The Healthcare Equipment & Supplies and Healthcare Technology sectors were the industry s leaders with respect to valuation during Q4 2017, trading at revenue multiples of 4.3x and 2.6x, respectively. Offer Date Issuer Industry Sector Offering Type Offering Size ($mm) 11/14/17 Anthem, Inc. Managed Healthcare Fixed Income $5,495 11/08/17 Johnson & Johnson Pharmaceuticals Fixed Income $4,492 10/18/17 UnitedHealth Group, Inc. Managed Healthcare Fixed Income $3,979 10/31/17 Celgene Corp. Pharmaceuticals Fixed Income $2,994 11/27/17 IQVIA Holdings, Inc. Life Sciences Secondary $1,020 11/13/17 Alnylam Pharmaceuticals, Inc. Biotechnology Secondary $675 12/07/17 Denali Therapeutics, Inc. Biotechnology IPO $250 11/05/17 TissueGene, Inc. Biotechnology IPO $181 12/06/17 Odonate Therapeutics, Inc. Pharmaceuticals IPO $150 11/29/17 Teladoc, Inc. Healthcare Technology Secondary $150 Public Market Performance (LTM) Public Company Market Performance by Sector 140% 130% 120% 110% 100% 90% 27.2% 18.4% 17.5% Median Change in Stock Price Enterprise Value / LTM Industry Sector 3 Months 12 months Revenue EBITDA Healthcare Facilities 4.5% 13.3% 1.2x 9.1x Healthcare Services 10.3% 9.5% 2.0x 11.3x Managed Healthcare 10.9% 42.1% 0.5x 10.3x Healthcare Technology (6.3%) 30.2% 2.6x 19.8x Healthcare Equipment & Supplies 4.6% 22.8% 4.3x 18.6x 80% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Healthcare Distribution (3.1%) (3.3%) 0.2x 9.9x S&P 500 Nasdaq S&P Global Healthcare Index Source: S&P Capital IQ 2

Total Transaction Volume Total Transaction Value ($ in billions) Annual Middle Market M&A Activity Healthcare Commentary Middle Market M&A Transactions by Deal Size Healthcare As detailed in the

Middle Market Healthcare deal volume fell 35% throughout 2017 to 221 completed transactions, down from 338 during the prior year period. Middle Market Healthcare deal value fell 34% to $31.

3 Total Transaction Volume Total Transaction Value ($ in billions) Annual Middle Market M&A Activity Healthcare Commentary Middle Market M&A Transactions by Deal Size Healthcare As detailed in the charts below, Healthcare Middle Market M&A transaction volume and value decreased during 2017 compared to Middle Market Healthcare deal volume fell 35% throughout 2017 to 221 completed transactions, down from 338 during the prior year period. Middle Market Healthcare deal value fell 34% to $31.9 billion compared to $48.0 billion in the prior year. We expect M&A activity in the Healthcare industry will rebound in 2018 as uncertainty around the Affordable Care Act is resolved. ($ in billions) Deal Size Volume Value Volume Value Volume Value Less than $100M 218 $ $5.5 (35%) (29%) $100 - $499M 91 $ $14.6 (35%) (31%) $500 - $999M 29 $ $11.8 (28%) (38%) Total Middle Market 338 $ $31.9 (35%) (34%) % of Middle Market % Change Less than $100M 64% 16% 64% 17% $100 - $499M 27% 44% 27% 46% $500 - $999M 9% 40% 9% 37% Total Middle Market 100% 100% 100% 100% U.S. Middle Market M&A Activity Annual Trends: VOLUME U.S. Middle Market M&A Activity Annual Trends: VALUE $60 $50 $47.1 $46.2 $51.2 $42.8 $48.4 $49.0 $ $40 $30 $33.7 $35.3 $38.4 $22.8 $ $10 0 $ Less than $100M $100 - $499M $500 - $1,000M Less than $100M $100 - $499M $500 - $1,000M Source: S&P Capital IQ (middle market includes all closed deals with disclosed deal value between $10 million and $1 billion). 3

Total Transaction Volume Total Transaction Value ($ in billions) Quarterly Middle Market M&A Activity Healthcare Commentary Middle Market M&A Transactions by Deal Size Healthcare As detailed in the

The total value of completed Middle Market Healthcare deals fell 21% to $7.7 billion in Q4 2017, down from $9.

4 Total Transaction Volume Total Transaction Value ($ in billions) Quarterly Middle Market M&A Activity Healthcare Commentary Middle Market M&A Transactions by Deal Size Healthcare As detailed in the table on the right, Middle Market M&A activity in the Healthcare industry fell during Q to 48 closed transactions, a 39% decrease from the 79 transactions closed in Q The total value of completed Middle Market Healthcare deals fell 21% to $7.7 billion in Q4 2017, down from $9.7 billion in the prior year period, with the largest decline in transactions valued less than $100 million. M&A activity in the Healthcare industry dropped during all four quarters in 2017 because of uncertainty surrounding the Affordable Care Act. ($ in billions) Deal Size Volume Value Volume Value Volume Value Less than $100M 57 $ $1.2 (51%) (38%) $100 - $499M 15 $ $2.8 0% (9%) $500 - $999M 7 $4.6 5 $3.7 (29%) (21%) Total Middle Market 79 $ $7.7 (39%) (21%) % of Middle Market Q Q % Change Less than $100M 72% 20% 58% 16% $100 - $499M 19% 32% 31% 36% $500 - $999M 9% 48% 11% 48% Total Middle Market 100% 100% 100% 100% U.S. Middle Market M&A Activity Quarterly Trends: VOLUME U.S. Middle Market M&A Activity Quarterly Trends: VALUE $20 $ $15 $10 $11.9 $10.5 $8.7 $12.7 $15.2 $12.3 $10.9 $9.7 $9.9 $8.6 $9.4 $ $5 0 $0 Q4 '14 Q1 '15 Q2 '15 Q3 '15 Q4 '15 Q1 '16 Q2'16 Q3'16 Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q4 '14 Q1 '15 Q2 '15 Q3 '15 Q4 '15 Q1 '16 Q2'16 Q3'16 Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Less than $100M $100 - $499M $500 - $1,000M Less than $100M $100 - $499M $500 - $1,000M Source: S&P Capital IQ (middle market includes all closed deals with disclosed deal value between $10 million and $1 billion) 4

5 Recent M&A Activity Healthcare Select Announced M&A Transactions (Q4 2017) Enterprise EV / EV / Announced Date Target Buyer Industry Value ($mm) Revenue EBITDA 12/27/17 PetVet Care Centers, Inc. KKR & Co. Healthcare Facilities NA NA NA 12/27/17 Wellpartner, Inc. CVS Health Corp. Healthcare Services NA NA NA 12/26/17 Sucampo Pharmaceuticals, Inc. Mallinckrodt Public Ltd., Co. Pharmaceuticals $1, x 10.7x 12/22/17 Ignyta, Inc. Roche Holdings, Inc. Biotechnology $1,823.8 NA NA 12/19/17 Kindred Healthcare, Inc. TPG Capital / Welsh, Carson, Anderson & Stowe Healthcare Facilities $4, x 9.2x 12/18/17 MedRisk, Inc. The Carlyle Group Healthcare Services NA NA NA 12/18/17 Net Health Systems, Inc. The Carlyle Group Healthcare Technology NA NA NA 12/07/17 Advance Health New Mountain Capital Healthcare Services NA NA NA 12/07/17 Entellus Medical, Inc. Stryker Corp. Healthcare Equipment $ x NA 12/06/17 DaVita Medical Group Optum, Inc. Healthcare Services $4,900.0 NA NA 12/05/17 Cell Design Labs, Inc. Kite Pharma, Inc. Biotechnology $521.3 NA NA 12/03/17 Aetna, Inc. CVS Health Corp. Managed Healthcare $78, x 13.1x 11/29/17 Remedy Health Media, LLC Praesidian Capital / Topspin Partners Healthcare Technology NA NA NA 11/27/17 MGC Diagnostics Corp. Altus Capital Healthcare Equipment $ x 24.4x 11/20/17 H.D. Smith, LLC AmerisourceBergen Corp. Healthcare Distributors $815.0 NA NA 11/16/17 Almost Family, Inc. LHC Group, Inc. Healthcare Services $1, x 23.9x 11/15/17 MDVIP, Inc. Leonard Green & Partners Managed Healthcare NA NA NA Source: S&P Capital IQ. 5

6 Recent M&A Activity Healthcare Select Announced M&A Transactions (Q4 2017) Enterprise EV / EV / Announced Date Target Buyer Industry Value ($mm) Revenue EBITDA 11/15/17 Leehar Distributors, Inc. Diplomat Pharmacy, Inc. Healthcare Services $595.6 NA NA 11/14/17 TrialCard, Inc. Odyssey Investment Partners Healthcare Services NA NA NA 11/13/17 Upsher-Smith Laboratories, LLC Sumitomo Corp. of Americas Pharmaceuticals $1, x NA 11/09/17 Principia Biopharma, Inc. Sanofi Biotechnology $805.0 NA NA 11/06/17 RXC Acquisition Co. McKesson Specialty Health Healthcare Services $735.0 NA NA 11/01/17 Halyard Health, Inc., (Surgical and Infection Prevention Business) Owens & Minor, Inc. Healthcare Supplies $710.0 NA NA 10/30/17 Crown Laboratories, Inc. Hildred Capital Partners Pharmaceuticals NA NA NA 10/26/17 Health Integrated, Inc. ExlService Holdings, Inc. Healthcare Services NA NA NA 10/23/17 U.S. Healthworks, Inc. Concentra, Inc. Healthcare Facilities $753.0 NA 11.3x 10/23/17 Exactech, Inc. TPG Capital, L.P. Healthcare Equipment $ x 16.5x 10/11/17 Summit Behavioral Healthcare, LLC FFL Partners / Lee Equity Partners Healthcare Facilities NA NA NA 10/10/17 Delphi Behavioral Health Group, LLC The Halifax Group Healthcare Services NA NA NA 10/10/17 evicore healthcare, LLC Express Scripts Co. Healthcare Technology $3,600.0 NA NA 10/10/17 MedHelp International, Inc. The Staywell Co., LLC Healthcare Technology NA NA NA 10/05/17 Tea Leaves Health, LLC Welltok, Inc. Health Care Technology $90.0 NA NA 10/04/17 Fermatex Vascular Technologies, LLC Vance Street Capital Healthcare Equipment NA NA NA 10/02/17 Apama Medical, Inc. Boston Scientific Corp. Healthcare Equipment $300.0 NA NA Source: S&P Capital IQ. 6

7 M&A Activity by Healthcare Sector U.S. Middle Market M&A Activity by Healthcare Sector: VOLUME % Change Healthcare Facilities % *Healthcare Services % Healthcare Technology % Healthcare Equipment & Supplies % Pharmaceuticals, Biotechnology & Life Sciences % Q Q U.S. Middle Market M&A Activity by Healthcare Sector: VALUE % Change ($ in billions) Healthcare Facilities $0.8 $3.2 76% *Healthcare Services $1.3 $1.9 53% Healthcare Technology $0.6 $0.7 15% Healthcare Equipment & Supplies $0.8 $ % Pharmaceuticals, Biotechnology & Life Sciences $2.6 $3.8 31% $0.0 $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 $4.0 Q Q Source: S&P Capital IQ (includes all closed deals with disclosed deal value between $10 million and $1 billion). *Managed Healthcare and Healthcare Distribution transactions are included in the Healthcare Services sector. 7

8 Transaction Volume Private Equity Activity Healthcare Commentary Select Announced Private Equity M&A Transactions (Q4 2017) As detailed in the chart to the right, financial sponsors were active across many sectors of the Healthcare industry during Q4 2017, most notably in Healthcare Facilities with 21 announced deals. Several notable private equity deals were announced during Q4 2017, including: TPG Capital s proposed purchase of Exactech, Inc. for $721 million, KKR & Co s announced acquisition of PetVet Care Centers, Inc., and The Carlyle Group s proposed purchase of Net Health Systems, Inc. During Q4 2017, financial sponsors were most active in the Healthcare Facilities and Healthcare Services sectors, announcing 20 and 11 transactions respectively. Announced Date Target Buyer Industry Enterprise Value ($mm) EV / Revenue 12/27/17 PetVet Care Centers, Inc. KKR & Co. Healthcare Facilities NA NA NA 12/18/17 Net Health Systems, Inc. The Carlyle Group Healthcare Technology NA NA NA 12/18/17 MedRisk, Inc. The Carlyle Group Healthcare Services NA NA NA 12/07/17 Advance Health New Mountain Capital Healthcare Services NA NA NA 11/29/17 Remedy Health Media, LLC Praesidian Capital / Topspin Partners EV / EBITDA Healthcare Technology NA NA NA 11/28/17 ClearChoice Holdings, LLC Sun Capital Partners Healthcare Facilities NA NA NA 11/27/17 MGC Diagnostics Corp. Altus Capital Partners Healthcare Equipment $50 1.1x 24.4x 11/20/17 Ibs Pharma, LLC New Harbor Capital Management Healthcare Distributors NA NA NA Financial Sponsors Activity by Sector 11/15/17 MDVIP, Inc. Leonard Green & Partners Managed Healthcare NA NA NA 25 11/14/17 TrialCard, Inc. Odyssey Investment Partners Healthcare Services NA NA NA /14/17 Grand River Aseptic Manufacturing, Inc. Arlington Capital Partners Life Sciences NA NA NA 10/30/17 Crown Laboratories, Inc. Hildred Capital Partners Pharmaceuticals NA NA NA 15 10/30/17 Young Innovations Inc. The Jordan Company / Linden Healthcare Equipment NA NA NA /23/17 Exactech, Inc. TPG Capital Healthcare Equipment $ x 16.5x /20/17 Cirrus Medical Staffing, Inc. Webster Capital Healthcare Services $37 NA NA /11/17 Summit Behavioral Healthcare, LLC FFL Partners / Lee Equity Partners Healthcare Facilities NA NA NA 0 Healthcare Equipment & Supplies Healthcare Technology Healthcare Facilities Pharmaceuticals, Biotechnology & Life Sciences Healthcare Services Source: S&P Capital IQ. Graphic includes transactions with undisclosed transaction values. *Hyde Park Capital served as exclusive financial advisor to the seller. 10/10/17 Delphi Behavioral Health Group, LLC The Halifax Group Healthcare Services NA NA NA 10/04/17 Fermatex Vascular Technologies, LLC Vance Street Capital Healthcare Equipment NA NA NA 8

9 Industry Sector Overview Recent Stock Price Performance Commentary Healthcare Services The charts included on the following pages detail the recent stock price performance by sector for the leading public companies within the Healthcare industry for the 12-month period ended December 31, The shaded section is the most recent 3- month period (Q4) for each sector relative to the S&P 500. For the 12-month period ending December 31, 2017, the majority of the Healthcare industry had positive performances, led by the Managed Healthcare sector (up 42.1%) and the Healthcare Technology sector (up 30.2%). 130% 120% 110% 100% 90% 18.4% 9.5% During the 3-month period ended December 31, 2017, Healthcare industry sectors reported mostly positive performances, led by the Managed Healthcare sector (up 10.9%). 80% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 S&P 500 Healthcare Services Healthcare Facilities Managed Healthcare 130% 150% 120% 110% 140% 18.4% 130% 13.3% 120% 42.1% 18.4% 100% 110% 100% 90% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Source: S&P Capital IQ S&P 500 Healthcare Facilities 90% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 S&P 500 Managed Healthcare 9

10 Industry Sector Overview Recent Stock Price Performance Healthcare Technology Healthcare Equipment & Supplies 150% 140% 140% 130% 130% 30.2% 22.8% 120% 120% 18.4% 18.4% 110% 110% 100% 100% 90% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 90% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 S&P 500 Healthcare Technology S&P 500 Healthcare Equipment & Supplies Healthcare Distribution 130% 120% 18.4% 110% 100% 3.3% 90% 80% Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Source: S&P Capital IQ S&P 500 Healthcare Distribution 10

11 Industry Sector Overview Public Company Analysis ($ in millions, except per share) Healthcare Facilities Closing Price % of 52 Equity Enterprise Enterprise Value / LTM LTM Margins LTM Company Ticker 12/29/17 Week High Value Value Revenue Gross Profit EBITDA Gross Profit EBITDA Revenue EBITDA HCA Holdings, Inc. HCA $ % $33,153 $67,052 $42,693 $15,880 $8, % 18.8% 1.6x 8.3x Tenet Healthcare Corp. THC $ % $1,520 $18,459 $19,061 $6,669 $1, % 10.5% 1.0x 9.3x Universal Health Services, Inc. UHS $ % $11,004 $15,050 $10,243 $4,276 $1, % 16.6% 1.5x 8.9x Community Health Systems, Inc. CYH $ % $475 $14,485 $16,764 $6,187 $1, % 9.9% 0.9x 8.8x Encompass Health Corp. EHC $ % $4,901 $7,914 $3,844 $1,582 $ % 21.3% 2.1x 9.6x Select Medical Holdings Corp. SEM $ % $2,273 $5,696 $4,299 $831 $ % 11.5% 1.3x 11.6x Lifepoint Hospitals, Inc. LPNT $ % $2,047 $4,951 $6,406 $2,075 $ % 11.7% 0.8x 6.6x Hanger Orthopedic Group, Inc. HNGR $ % $556 $1,073 $1,012 $334 $ % 6.9% 1.1x 15.4x Average 79.5% $6,991 $16,835 $13,040 $4,729 $1, % 13.4% 1.3x 9.8x Median 87.4% $2,160 $11,200 $8,324 $3,176 $1, % 11.6% 1.2x 9.1x Healthcare Services Enterprise Value / Closing Price % of 52 Equity Enterprise LTM LTM Margins LTM Company Ticker 12/29/17 Week High Value Value Revenue Gross Profit EBITDA Gross Profit EBITDA Revenue EBITDA Laboratory Corp. of America Holdings LH $ % $16,601 $23,437 $9,892 $3,336 $1, % 19.2% 2.4x 12.3x DaVita, Inc. DVA $ % $14,040 $23,367 $15,213 $4,008 $2, % 16.0% 1.5x 9.6x Quest Diagnostics, Inc. DGX $ % $13,764 $17,366 $7,634 $2,959 $1, % 18.8% 2.3x 12.1x MEDNAX, Inc. MD $ % $4,975 $6,742 $3,378 $1,042 $ % 17.7% 2.0x 11.3x RadNet, Inc. RDNT $ % $475 $1,093 $912 $194 $ % 12.7% 1.2x 9.4x Average 88.4% $9,971 $14,401 $7,406 $2,308 $1, % 16.9% 1.9x 10.9x Median 87.2% $13,764 $17,366 $7,634 $2,959 $1, % 17.7% 2.0x 11.3x Source: S&P Capital IQ. 11

12 Industry Sector Overview Public Company Analysis ($ in millions, except per share) Managed Healthcare Closing Price % of 52 Equity Enterprise Company Ticker 12/29/17 Week High Value Value Revenue Gross Profit EBITDA Gross Profit EBITDA Revenue EBITDA Unitedhealth Group, Inc. UNH $ % $215,885 $227,523 $196,633 $46,167 $16, % 8.2% 1.2x 14.1x Aetna, Inc. AET $ % $62,677 $65,689 $62,197 $16,398 $6, % 9.7% 1.1x 10.8x Cigna Corp. CI $ % $52,675 $53,748 $40,527 $13,279 $4, % 10.4% 1.3x 12.8x Anthem, Inc. ANTM $ % $60,578 $51,451 $89,073 $17,942 $5, % 6.4% 0.6x 9.0x Humana, Inc. HUM $ % $36,992 $25,835 $53,868 $9,552 $2, % 4.9% 0.5x 9.7x Centene Corp. CNC $ % $17,779 $17,710 $44,870 $8,028 $2, % 4.9% 0.4x 8.0x WellCare Health Plans, Inc. WCG $ % $9,009 $5,647 $15,361 $2,125 $ % 4.1% 0.4x 9.1x Magellan Health Services, Inc. MGLN $ % $2,306 $2,667 $5,280 $290 $ % 4.6% 0.5x 11.0x LTM LTM Margins Enterprise Value / LTM Average 95.1% $57,238 $56,284 $63,476 $14,223 $4, % 6.7% 0.7x 10.6x Median 95.2% $44,833 $38,643 $49,369 $11,416 $3, % 5.7% 0.5x 10.3x Healthcare Technology Closing Price % of 52 Equity Enterprise Enterprise Value / LTM LTM Margins LTM Company Ticker 12/29/17 Week High Value Value Revenue Gross Profit EBITDA Gross Profit EBITDA Revenue EBITDA Cerner Corp. CERN $ % $22,806 $22,489 $4,988 $4,246 $1, % 27.8% 4.5x 16.2x Athenahealth, Inc. ATHN $ % $5,395 $5,548 $1,179 $614 $ % 11.0% 4.7x 42.6x* Allscripts Healthcare Solutions, Inc. MDRX $ % $2,640 $4,414 $1,714 $862 $ % 10.1% 2.6x 25.4x Medidata Solutions, Inc. MDSO $ % $3,742 $3,618 $529 $405 $ % 15.5% 6.8x* 44.1x* Quality Systems, Inc. QSII $ % $851 $880 $524 $296 $ % 11.3% 1.7x 14.9x Healthstream, Inc. HSTM $ % $745 $622 $244 $138 $ % 11.1% 2.6x 22.9x Computer Programs & Systems, Inc. CPSI $ % $402 $546 $263 $140 $ % 10.5% 2.1x 19.8x Average 82.5% $5,226 $5,445 $1,349 $957 $ % 13.9% 3.0x 19.8x Median 83.1% $2,640 $3,618 $529 $405 $ % 11.1% 2.6x 19.8x Source: S&P Capital IQ. *Excluded from average and median calculation. 12

13 Industry Sector Overview Public Company Analysis ($ in millions, except per share) Healthcare Equipment & Supplies Closing Price % of 52 Equity Enterprise Enterprise Value / LTM LTM Margins LTM Company Ticker 12/29/17 Week High Value Value Revenue Gross Profit EBITDA Gross Profit EBITDA Revenue EBITDA Medtronic, Inc. MDT $ % $111,169 $126,832 $29,639 $20,525 $9, % 30.9% 4.3x 13.8x Stryker Corp. SYK $ % $58,781 $63,277 $12,130 $8,041 $3, % 27.4% 5.2x 19.1x Becton, Dickinson and Co. BDX $ % $47,861 $52,526 $12,093 $5,942 $3, % 27.6% 4.3x 15.8x DENTSPLY International, Inc. XRAY $ % $15,131 $16,396 $3,899 $2,137 $ % 21.1% 4.2x 20.0x Teleflex, Inc. TFX $ % $11,640 $12,873 $2,065 $1,156 $ % 26.9% 6.2x 23.2x The Cooper Companies, Inc. COO $ % $10,807 $11,891 $2,139 $1,377 $ % 30.8% 5.6x 18.0x Varian Medical Systems, Inc. VAR $ % $10,359 $9,997 $2,668 $1,156 $ % 18.1% 3.7x 20.7x Steris Corp. STE $ % $7,503 $8,664 $2,570 $1,061 $ % 21.3% 3.4x 15.8x Average 92.9% $34,156 $37,807 $8,400 $5,174 $2, % 25.5% 4.6x 18.3x Median 93.4% $13,386 $14,634 $3,284 $1,757 $ % 27.1% 4.3x 18.6x Healthcare Distribution Enterprise Value / Closing Price % of 52 Equity Enterprise LTM LTM Margins LTM Company Ticker 12/29/17 Week High Value Value Revenue Gross Profit EBITDA Gross Profit EBITDA Revenue EBITDA McKesson Corp. MCK $ % $33,451 $40,983 $201,955 $11,003 $3, % 1.9% 0.2x 10.5x Cardinal Health, Inc. CAH $ % $19,545 $28,396 $130,578 $6,626 $3, % 2.3% 0.2x 9.3x AmerisourceBergen Corp. ABC $ % $20,347 $21,706 $153,144 $4,545 $2, % 1.6% 0.1x 8.9x Henry Schein, Inc. HSIC $ % $11,139 $13,362 $12,264 $3,365 $1, % 8.4% 1.1x 12.9x Patterson Companies, Inc. PDCO $ % $3,408 $4,406 $5,532 $1,280 $ % 7.1% 0.8x 11.3x Owens & Minor, Inc. OMI $ % $1,134 $1,953 $9,297 $1,152 $ % 2.3% 0.2x 9.1x Average 76.4% $14,837 $18,468 $85,462 $4,662 $1, % 3.9% 0.4x 10.3x Median 74.8% $15,342 $17,534 $71,421 $3,955 $1, % 2.3% 0.2x 9.9x Source: S&P Capital IQ. 13

Integrity Expertise Results John Hill Senior Managing Director hill@hydeparkcapital.

com (813) 383-0207 has been recapitalized by has received a growth equity

com (678) 523-3073 & Tim Knerr Vice President knerr@hydeparkcapital.

14 Integrity Expertise Results John Hill Senior Managing Director (813) Recent Transactions John McDonald Senior Managing Director (813) a subsidiary of has been recapitalized by Keith Hodgdon Managing Director hodgdon@hydeparkcapital.com (813) Charlie Hendrick Vice President hendrick@hydeparkcapital.com (813) has been recapitalized by has received a growth equity investment from Jeffrey Hendricks Vice President jhendricks@hydeparkcapital.com (678) & Tim Knerr Vice President knerr@hydeparkcapital.com (813) Hyde Park Capital Advisors, LLC 701 N. Franklin Street Tampa, FL Tel: has been recapitalized by & has been recapitalized by Minera del Norte S.A. de C.V. Member FINRA/SIPC

Healthcare M&A Report Q2 2018

Healthcare M&A Report Q2 2018 Integrity Expertise Results John Hill Senior Managing Director hill@hydeparkcapital.com (813) 383-0205 John McDonald Senior Managing Director mcdonald@hydeparkcapital.com (813) 383-0206 Healthcare M&A